Search

MSK researchers used the genome-editing tool CRISPR to create more potent chimeric antigen receptor (CAR) T cells that don't tire as easily when attacking cancer cells. The unexpected findings were published in the journal Nature on February 22 and underscore the potential of genome editing to advance immunotherapy for cancer.

… Wednesday, February 22, 2017 Researchers from Memorial Sloan Kettering Cancer Center (MSK) have harnessed the power of CRISPR/Cas9 to create more-potent chimeric antigen receptor (CAR) T cells that enhance tumor rejection in mice. The unexpected findings, published in Nature on February 22, uncover facets

Physician-scientist Liang Deng studies poxvirus interface with the immune system and the development of poxviruses as oncolytic and immunotherapy for cancers.

… Our laboratory is focused on understanding how poxviruses are detected by the host innate immune sensing mechanisms and how poxviruses evade host antiviral responses. We are also interested in the development of poxvirus-based oncolytic and immunotherapy for cancers including melanoma. Figure 1 Poxviruses

On November 10, 2025, hundreds gathered in the Mortimer B. Zuckerman Research Center for the “MSK Innovation with Lasting Impact Summit: Entrepreneurship & Innovation at MSK,” at an event that brought together laboratory and clinical researchers, digital health innovators, healthcare executives, and investors.

… Thursday, December 18, 2025 On November 10, 2025, hundreds gathered in the Mortimer B. Zuckerman Research Center for the “MSK Innovation with Lasting Impact Summit: Entrepreneurship & Innovation at MSK,” at an event that brought together laboratory and clinical researchers, digital health innovators,

Our experts are ready to help with compassionate care and the most-advanced melanoma immunotherapy options available. Read about our approach and how we can help.

… Immunotherapy is a method of treating cancer that uses drugs to empower the immune system to recognize and fight cancer. MSK has been a pioneer in developing immunotherapy. The approach has proven very effective in treating advanced melanoma. There are several forms of immunotherapy. The immunotherapy

Nuestros expertos están listos para ayudar con la atención compasiva y las opciones de inmunoterapia para tratar el melanoma más avanzadas disponibles. Lea sobre nuestro enfoque y cómo podemos ayudar.

… La inmunoterapia es un método de tratamiento del cáncer que utiliza fármacos para enseñar al sistema inmunitario a reconocer y combatir el cáncer. MSK ha sido pionero en el desarrollo de la inmunoterapia. El enfoque ha demostrado ser muy eficaz en el tratamiento del melanoma avanzado. Existen varias

… The Antibody and Bioresource Core Facility supports researchers by making it easier for them to develop new monoclonal antibodies (MAbs). This is accomplished by being an informational resource as well as by providing various services. New MAbs Primary Services The facility works with researchers to

Learn about MSK’s active surveillance program for papillary thyroid cancer, which allows many people to avoid unnecessary surgery and the risks that come with it.

… Wednesday, November 13, 2024 Advances in cancer detection have saved many lives, but they have a serious drawback: Some cancers are being overdiagnosed, which can lead to the unnecessary treatment of tumors that would have posed no threat if left alone.  One cancer that may not need treatment right away

Christopher Gerry studies organic chemistry and chemical biology in the Tan laboratory at MSKCC.

… Job Title Summer Intern Graduate Student, 2014–present with Prof. Stuart L. Schreiber Department of Chemistry & Chemical Biology Harvard University BS, Amherst College, 2014 Rubin and Sarah Shaps Scholar, 2012 Summer Undergraduate Research Intern, 2012 Gerstner Sloan Kettering Graduate School Publications

… Tea will be served at 11:45 a.m. , immediately preceding the seminar. Audience This seminar is open to the research community. Location Memorial Sloan Kettering Cancer Center Zuckerman Research Center 417 East 68th Street Room ZRC-105 New York, NY 10065 Speaker(s) Taekjip (TJ) Ha, PhD Professor Department